메뉴 건너뛰기
Clinical Pharmacokinetics
Volumn 43, Issue 14, 2004, Pages 1055-1057
Modelling ciclosporin double-peak absorption profiles in the early post-transplantation period
Author keywords

[No Author keywords available]
Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
EID: 10044263157     PISSN: 03125963     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003088-200443140-00007     Document Type: Article
Times cited : (3)
References (7)
  • 1
    • 0037275847 scopus 로고    scopus 로고
    • A modified two-portion absorption model to describe double-peak absorption profiles of ranitidine
    • Yin OQP, Tomlinson B, Chow AHL, et al. A modified two-portion absorption model to describe double-peak absorption profiles of ranitidine. Clin Pharmacokinet 2003; 42(2): 179-92
    • (2003) Clin Pharmacokinet , vol.42 , Issue.2 , pp. 179-192
    • Yin, O.Q.P.1    Tomlinson, B.2    Chow, A.H.L.3
  • 2
    • 0034973958 scopus 로고    scopus 로고
    • Application of a gamma model of absorption to oral cyclosporin
    • Debord J, Risco E, Harel M, et al. Application of a gamma model of absorption to oral cyclosporin. Clin Pharmacokinet 2001; 40 (5): 375-82
    • (2001) Clin Pharmacokinet , vol.40 , Issue.5 , pp. 375-382
    • Debord, J.1    Risco, E.2    Harel, M.3
  • 3
    • 0036171322 scopus 로고    scopus 로고
    • Maximum a posteriori Bayesian estimation of oral cyclosporin pharmacokinetics in patients with stable renal transplants
    • Leger F, Debord J, Le Meur Y, et al. Maximum a posteriori Bayesian estimation of oral cyclosporin pharmacokinetics in patients with stable renal transplants. Clin Pharmacokinet 2002: 41 (1): 71-80
    • (2002) Clin Pharmacokinet , vol.41 , Issue.1 , pp. 71-80
    • Leger, F.1    Debord, J.2    Le Meur, Y.3
  • 4
    • 0037305992 scopus 로고    scopus 로고
    • Bayesian forecasting of oral cyclosporin pharmacokinetics in stable lung transplant recipients with and without cystic fibrosis
    • Rousseau A, Monchaud C, Debord J, et al. Bayesian forecasting of oral cyclosporin pharmacokinetics in stable lung transplant recipients with and without cystic fibrosis. Ther Drug Monit 2003; 25 (1): 28-35
    • (2003) Ther Drug Monit , vol.25 , Issue.1 , pp. 28-35
    • Rousseau, A.1    Monchaud, C.2    Debord, J.3
  • 6
    • 0036766650 scopus 로고    scopus 로고
    • Adequate early cyclosporin exposure is critical to prevent renal allograft rejection: Patients monitored by absorption profiling
    • Clase CM, Mahalati K, Kiberd BA, et al. Adequate early cyclosporin exposure is critical to prevent renal allograft rejection: patients monitored by absorption profiling. Am J Transplant. 2002; 2 (8): 789-95
    • (2002) Am J Transplant , vol.2 , Issue.8 , pp. 789-795
    • Clase, C.M.1    Mahalati, K.2    Kiberd, B.A.3
  • 7
    • 0037181448 scopus 로고    scopus 로고
    • Improved clinical outcomes for liver transplant recipients using cyclosporine monitoring based on 2-hr post-dose levels (C2)
    • Levy G, Burra P, Cavallari A, et al. Improved clinical outcomes for liver transplant recipients using cyclosporine monitoring based on 2-hr post-dose levels (C2). Transplantation 2002; 73 (6): 953-9
    • (2002) Transplantation , vol.73 , Issue.6 , pp. 953-959
    • Levy, G.1    Burra, P.2    Cavallari, A.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.